Serplulimab Combined With SHR-A1811 as Neoadjuvant Therapy for Triple-Negative Breast Cancer
1 clinical trials · Condition
◉ Watch Serplulimab Combined With SHR-A1811 as Neoadjuvant Therapy for Triple-Negative Breast Cancer
| Record | Firm | Date |
|---|
Track Serplulimab Combined With SHR-A1811 as Neoadjuvant Therapy for Triple-Negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.